Rokitamycin
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-2,4-dimethyl-4-propoxyoxan-3-yl butanoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
CAS number | 74014-51-0 |
ATC code | J01FA12 |
PubChem | CID 5282211 |
ChemSpider | 4445397 |
UNII | ZPT03UEM0E |
ChEMBL | CHEMBL556528 |
Chemical data | |
Formula | C42H71NO14 |
Mol. mass | 827.999 g/mol |
SMILES
| |
| |
Physical data | |
Melt. point | 116 °C (241 °F) |
Solubility in water | Insoluble in water; Very soluble in chloroform and methanol; Almost completely (>99.5 %) in ethanol and acetonitrile. mg/mL (20 °C) |
(what is this?) (verify) | |
Rokitamycin is a macrolide antibiotic. Synthesized from strains of Streptomyces kitasatoensis.
|
External links
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.